IVTEAM
Patient benefits and economic sustainability of OPAT
"The OPAT v2.0 model demonstrates clinical and economic effectiveness, reducing hospital costs and improving quality of care" Lacerenza et al (2026).
Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 49-60 of 1719 results.
"The OPAT v2.0 model demonstrates clinical and economic effectiveness, reducing hospital costs and improving quality of care" Lacerenza et al (2026).
"In this study, we aimed to develop a survival model to facilitate personalised CRT prevention strategies" Ge et al (2026).
"This article emphasizes the importance of strict hygiene regulations in anesthesia and functional areas to prevent nosocomial infections" Schulz-Stübner and Bushuven (2026)
"We evaluated the technical and clinical outcomes of Viabahn VBX stent grafts used for reconstructing the CAJ lesion in hemodialysis patients with SVC syndrome" Yu et al (2026).
"Multidisciplinary engagement and structured protocols significantly enhanced recognition and response to extravasation injuries in critical care. Broader adoption of national guidance and continued education may further reduce harm and promote consistency in intravenous therapy practices across acute care settings" Millen (2026).
"This review will identify techniques and technologies that improve PIVC insertion success and function in the ED. By analysing pooled outcomes, the researchers aim to provide recommendations to enhance PIVC insertion success, and ultimately patient outcomes" Daglish et al (2026).
"This study underscores the safety of OPAT. Supported by a multidisciplinary team, the program effectively treated common infections primarily using ceftriaxone. Most patients maintained peripheral IV access without significant complications" Alsharrah and Jadavji (2026).
"Standardized venous assessment with objective escalation to ultrasound improves PIVC outcomes and eliminates observed racial- and sex-based disparities" Bahl et al (2026).
"DCA occurred in 21.01% of neonatal PICC insertions; Late insertion, weight < 1000 g at insertion, and lower-limb sites were independent risk factors, while intraprocedural ultrasound and first‑attempt puncture success were protective factors" Wei et al (2026).
"Obtaining central venous access is a priority in the management of every critically ill patient, since it provides a more stable access than peripheral vascular access and allows the administration of several drugs simultaneously (multi-lumen catheters), even irritating medications, and the performance of techniques (such as dialysis with a proper catheter)" Veiga et al (2026).
"The online training program significantly improved nurses' theoretical knowledge and reduced complications related to Midline devices. However, to achieve a broader impact on VAD-associated complications, structured and continuous training programs are needed" Aula et al (2026).
"Our study demonstrates a higher incidence of CRBSI in the Heparin group compared to the Taurolock solution and a similar effectiveness of the Taurolock solution in preventing catheter dysfunction over Heparin" Jeelani et al (2026).
